The phrase "attractive cost" is correct and usable in written English.
It can be used when describing a price or expense that is appealing or favorable to potential buyers or customers.
Example: "The new software package is available at an attractive cost, making it accessible for small businesses."
Alternatives: "appealing price" or "competitive cost".
The pricing for this acquisition would be at a discounted price to par value and an attractive cost basis.
Continuous basalt fibers present a unique combination of good mechanical and functional properties at an attractive cost level.
In addition, the associated reduction in fraction number produces attractive cost and patient convenience advantages as well.
The contractors and licensors designing and building such process plants are quite proficient at designing a plant to meet those performance values for an economically attractive cost.
In a future bio-based economy, renewable sources for lipid compounds at attractive cost are needed for applications where today petrochemical derivatives are dominating.
Vodafone chief executive Vittorio Colao said: "The acquisition of Cable & Wireless Worldwide creates a leading integrated player in the enterprise segment of the UK communications market and brings attractive cost savings to our UK and international operations".
Dried blood spots (DBS) could serve as an attractive, cost-effective alternative to plasma for HIV drug resistance testing.
From the experimental results and the analysis of the equilibrium diagrams of the major oxides present, the theoretical sintering temperatures were determined to be too high for an attractive cost-effective industrial scale process.
To our way of thinking, the new China continues to remain a most attractive, cost-efficient and competitive manufacturing resource.
Electrospray is an attractive, cost-effective and simple method for producing nano- and micro-particles that are used for drug delivery and other pharmaceutical purposes [9].
Vaccination plus biennial screening delayed until age 24 years had the most attractive cost-effectiveness ratio (44 889 dollars) compared with screening only beginning at age 18 years and conducted every 3 years.
